ARTICLE | Translation in Brief
Agenus scales the AI ALPS
How Agenus’ machine learning platform helps pick combos for clinical testing
April 18, 2019 8:04 PM UTC
Agenus is using its artificial intelligence, machine learning platform to match cancer patients with the best monotherapy or combination therapy it has, and to uncover mechanisms of resistance to develop new therapies using non-responder data.
The platform, called ALPS (Adaptive Learning Platform Systems), combines patient data from Agenus’ clinical trials with preclinical data from cellular and in vivo assays designed by Thomas Horn, a senior scientist at Agenus...
BCIQ Company Profiles